APA (7th ed.) Citation

Han, J., Yu, B., Jing, J., He, X., Hua, Y., & Xu, G. (2025). EGFR blockade confers sensitivity to pan-RAS inhibitors in KRAS-mutated cancers. Cellular Oncology (2211-3428), 48(5), 1317. https://doi.org/10.1007/s13402-025-01075-4

Chicago Style (17th ed.) Citation

Han, Junling, Bo Yu, Jianan Jing, Xiaoyu He, Yunfen Hua, and Guotai Xu. "EGFR Blockade Confers Sensitivity to Pan-RAS Inhibitors in KRAS-mutated Cancers." Cellular Oncology (2211-3428) 48, no. 5 (2025): 1317. https://doi.org/10.1007/s13402-025-01075-4.

MLA (9th ed.) Citation

Han, Junling, et al. "EGFR Blockade Confers Sensitivity to Pan-RAS Inhibitors in KRAS-mutated Cancers." Cellular Oncology (2211-3428), vol. 48, no. 5, 2025, p. 1317, https://doi.org/10.1007/s13402-025-01075-4.